FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical and food industry, in particular to medicines and dietary supplements with a sedative, anxiolytic and antispasmodic action. Sedative agent for express relaxation includes glycine, tryptophan, menthol and excipients in the following ratio, wt. %: glycine 50–65, tryptophan 20–30, menthol 1–3, excipients - the rest.
EFFECT: invention allows, due to a selected ratio of components, to obtain a biologically active agent with an accelerated manifestation of the sedative effect (express effect) and reduced side effects.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOBIOTIC COMPLEX | 2016 |
|
RU2706069C2 |
| COMBINED PREPARATION POSSESSING SEDATIVE, SPASMOLYTIC AND ANTI-ALLERGIC EFFECT | 2004 |
|
RU2295968C2 |
| PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
| SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
| AGENT "HITOEPIFIT" FOR TREATMENT OF EPILEPSY AND CONVULSIVE SYNDROME | 2002 |
|
RU2204407C1 |
| BIOLOGICALLY ACTIVE ADDITIVE WITH SEDATIVE-ANTIDEPRESSIVE EFFECT | 2016 |
|
RU2636471C1 |
| AGENT FOR TREATMENT OF INSOMNIA | 1990 |
|
RU2012347C1 |
| PLANT-DERIVED REMEDY WITH SEDATIVE EFFECT | 2017 |
|
RU2663806C1 |
| COMBINED HYPNOTIC AGENT IN THE FORM OF TABLETS | 2021 |
|
RU2769988C1 |
| TABLETS "LEONIRID" FOR TREATMENT OF PATIENTS WITH FUNCTIONAL DISORDERS OF CENTRAL AND VEGETATIVE NERVOUS SYSTEM | 1998 |
|
RU2145230C1 |
